2009, Number 5
<< Back Next >>
Rev Invest Clin 2009; 61 (5)
Clinical characteristics of the late-onset epilepsy in Mexico to the beginning of the new millennium: 455 cases
Suástegui R, Gutiérrez J, Ramos R, Bouchan S, Navarrete H, Ruiz J, Plascencia N, Jauri S, León C, Castillo V, Aveleyra OE
Language: Spanish
References: 55
Page: 354-363
PDF size: 109.22 Kb.
ABSTRACT
Introduction. Epilepsy is a multifactorial disorder, and several
factors can modify its prevalence in different regions.
Among these, local culture, public health policies and survival
rate can be cited. Alongside, the cause of epilepsy may be different
according to time and geographic registries. In Mexico,
neurocysticercosis remains a leading cause of seizures. Nonetheless,
lifestyle changes and the increase in life expectancy
have fostered the incidence of stroke. Both diseases are
the main underlying disorders causing epilepsy in Mexico. Lately,
their respective incidence is being reversed, and therefore
their role is gradually interchanging.
Objectives. To describe
and assess the epidemiological and clinical features of a
sample of Mexican patients with late-onset seizures.
Material
and methods. A group of 455 patients aged over 20 years
old was recruited from ten different centers nationwide. The
study included patients with onset of epilepsy from year 2000
on, and clinical features of seizures were recorded for every
patient, electroencephalogram (EEG) and brain computed tomography
(CT) were performed.
Results. No gender-related
differences were observed. Age distribution was as follows: the
highest incidence occurred in the third decade of life and 18%
of the patients were aged above 60 years old. Generalized seizures
were recorded in 49% of the patients. Pharmacological
management used a single drug in 83% of the patients and the
most frequently used drug was diphenylhydantoine (PHT)
and the second was carbamazepine (CBZ). Abnormal electroencephalographic
findings were recoded in 66% of the cases.
Concerning etiologies, the first cause was neurocysticerosis in
21% of the cases, followed by stroke in 17% of them. No cause
could be found in 49% of the patients. These findings slightly
differ from those of other centers in developed countries.
Conclusions. In the last decades, the societal changes in the
country have greatly influence the shift in the underlying
causes of late-onset seizures. Even if neurocysticercosis
stands still as the first cause, its frequency has declined by
more than 50% while the increase of stroke incidence has boosted
its etiological role and their difference is now statistically
non-significant.
REFERENCES
Hernández-Fustes OJ, Lope-Viscarraga H, Enríquez-Cáceres M, Hernández-Cossio O. Consideraciones acerca de las epilepsias tardías. Rev Neurol 2002; 34: 788-93.
Carda J, Quintana F, Dierssen F Montiaga F, Díaz J, Sanz F, et al. Epilepsia de aparición tardía no tumoral. Rev Clin Esp 1980; 156: 173-8.
Casteine P, Laplane D, Alajouanine TH. Epilepsies tardives de l’adulte. Rev Dur Practicien 1959; 13: 1377-80.
Lominchar J, Moya O. Las crisis epilépticas de comienzo tardío. Rev Clin Esp 1981; 163: 169-71.
Gerstie E, Pietra M, Guadín S. Etiología de la epilepsia tardía estudio de 155 casos. Acta Neurol Latinoamer 1972; 18: 256-75.
Martín R, Díaz C, Nuévalos C, Matías-Guiu J. Factores etiológicos y pronósticos en la epilepsia tardía. Rev Neurol 1995; 23: 285-9.
Ahuja O, Mohanta A. Late onset epilepsy. Acta Neurol Scand 1982; 66: 216-26.
Tomalá M, Sánchez X, Ordóñez P, Santos J. Epilepsia de inicio reciente en pacientes de 20 a 24 años de edad: epilepsia temprana o epilepsia tardía. Rev Ecuat Neurol 1993; 2: 134-6.
Pérez J, Longo J, Quintana F, Diez C, Berciano J. Late onset epileptic seizures. Acta Neurol Scand 1985; 72: 380-4.
Tuiran R. Desafíos del Envejecimiento Demográfico en México. En: Consejo Nacional de Población (CONAPO) (eds.). Envejecimiento Demográfico en México: Retos y Perspectivas. México; 1991.
Commission on Classification and Terminology of the International League against Epilepsy. Proposal for revised clinical and electro-encephalographic classification of epileptic seizures. Epilepsia 1981; 22: 489-501.
Hauser A. Incidence and prevalence. In: Engel J Jr, Pedley T (eds.). Epilepsy Maryland: Lippincott Williams & Wilkins Publishers; 1999, Cap.5.
Mateos JH. Cisticercosis cerebral en México como un problema de salud pública. Gac Med Mex 1972; 103: 225-50.
Anuario de Estadística de los Estados Unidos Mexicanos. México: Instituto Nacional de Geografía e Informática (INEGI); 2002.
Vasconcelos D, Lombardo L. Crisis epilépticas del adulto. Estudio prospectivo de 65 casos. Gac Med Mex 1983; 19: 23-7.
Medina MT, Rosas E, Rubio-Donnadieu F, Sotelo J. Neurocysticercosis as the main cause of late-onset: epilepsy in Mexico. Arch Inter Med 1990; 150: 325-7.
Rogel-Ortiz F. Epilepsia del adulto estudio prospectivo de 130 casos. Gac Med Mex 1999; 135: 363-8.
Hernández-Fustes OJ, Hernández-Cossio O, Munhoz RP, Kawasaki M, De la Silvia LF, Enríquez M, Hernández-Fustes J. Epilepsia de inicio tardío no tumoral: estudio en pacientes hospitalizados mayores de 30 años de edad. Rev Neurol 2001; 33: 395-5.
Schold C, Yarnell PR, Earnest MP. Origin of seizures in early patients. JAMA 1977; 238: 1177-8.
Lühdorf K, Jensen LK, Plesner AM. Etiology of seizures in the elderly. Epilepsia 1986; 27: 458-63.
Hernández-Cossio O, Hernández-Oramas N, Enríquez-Cáceres M, Hernández-Fustes OJ. Etiología de las epilepsias de comienzo tardío. Rev Neurol 2001; 32: 628-30.
Marrero C, Diez E, Ibáñez V, Barreiro P. Crisis epilépticas precoces y tardías tras isquemia cerebral hemisférica. Rev Neurol 1998; 27: 676-81.
Fernández-Concepción O, Gómez-García A, Bonet–Gorvea M. Cerebral tumors as a cause of late onset epilepsy. Rev Neurol 1999; 29: 1142-6.
Ettinger AB, Shinnar S. New-onset seizures in an elderly hospitalized population. Neurology 1993; 43: 489-92.
Carney LR, Hudgins RL, Espinosa RE, Klass DW. Seizure beginning after the age of 60. Arch Intern Med 1969; 124: 707-9.
Martínez-García FA, Villaverde R, Salmerón P, Morales A, Molto JM, Fernández-Barreiro A. Crisis epilépticas de comienzo tardío y enfermedad vascular cerebral. Rev Neurol 1998; 27: 671-5.
Lühdorf K, Jensen LK, Plesner AM. Epilepsy in the elderly: prognosis. Acta Neurol Scand 1986; 74: 409-15.
Sundaram M. Etiology and patterns of seizures in the elderly Neuroepidemiology 1989; 8: 234-8.
Thomas R. Seizures and epilepsy in the elderly. Arch Intern Med 1997; 157: 605-17.
Pérez-López FI, Martín-Martínez J, Bestué M, Oliveros A. Presentación precoz de crisis y evolución de la epilepsia en la hemorragia intraparenquimatosa cerebral. Rev Neurol 1999; 28: 305-9.
Teasel RW, McRae MP, Webe S. Poststroke seizures in stroke rehabilitation patients. J Stroke Cerebrovasc Dis 1999; 8: 84-7.
Kilpatrick CJ, Tress BM, O’Donnel JC, Rossiter SC, Hopper JL. Magnetic resonance imaging and late-onset epilepsy. Epilepsia 1991; 32: 358-64.
Santos S, Mauri JA, López del Val J, Tejero C, Morales F. Epilepsia sintomática revisión 208 casos. Rev Neurol 1999; 28: 846-9.
Mouritzen DA, Fuglsang-Frederiksen A, Syarre-Olsen U, Dam M. Late-onset epilepsy: etiologies, types of seizure and value of clinical investigation, EEG and computerized tomography scan. Epilepsia 1985; 26: 227-31.
Vasconcelos D, Lombardo L. Prospective study of late epilepsy cases. Acta Neurol Scand 1980; 62(Suppl.): 69-77.
Jiménez-Jiménez FJ, Molina-Adona JA, Zancada F, Santos J, Roldán-Montaud A, Femández-Ballesteros A. Etiology of lateonset epilepsy. A prospective study in an area rural health care. Med Clin (Barc) 1990; 14: 521-4.
Vasconcelos D. Crisis epilépticas como síntoma inicial de tumores intracraneales. Estudio prospectivo en adultos. Gac Med Mex 1990; 3: 169-74.
Rohmer D, Kurtz D. Les crises d’epilepsie de cause metabolique. Rev Dur Practicien 1968; 18: 4287-96.
Hildick-Smith M. Late-onset epilepsy. Br J Clin Pract 1994; 48: 87-90.
Sirven J. Epilepsy in older adults: causes, consequences and treatment. JAGS 1998; 46: 1291-301.
Hauser A, Annegers J, Kuríand L. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991; 32: 429-45.
Risse SC, Lampe TH, Bird TD, Nochlin D, Sumi SM, Keenan T, et al. Myocionus, seizures, and paratonia in Alzheimer disease. Alzheimer Dis Assoc Disord 1990; 4: 217-25.
Romanelli MF, Morris JC, Ashkin K, Coben LA. Advanced Alzheimer disease is a risk factor for late-onset seizures. Arch Neurol 1990; 47: 847-50.
De la Court A, Breteler M, Meinardi H, Hauser A, Hofinan A. Prevalence of epilepsy in the elderly: the Rotterdam study. Epilepsia 1996; 37: 141-7.
Sander JW, Shorvon SD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry 1996; 61: 433-43.
Sander JW. The epidemiology of epilepsy revised. Curr Opin Neurol 2003; 16: 165-70.
Brodie MJ, Shorvon SD, Canger R, Halasz P. Johannessen S, Thompson P, et al. Commission on European affairs: Appropriate Standards of epilepsy care across Europe. Epilepsia 1997; 38: 1245-50.
Blume WT, Young GB, Lemieux JF. EEG morphology of partial epileptic seizure. Electroencephalogr Clin Neurophysiol 1984; 57: 295-302.
Azoubel AC, Silveira DC, Guerreiro CA. Electroencephalographics evolution in women with refractaria epilepsy. Arq Neuropsiquiatr 1995; 53(3-A): 384-9.
Hakamada S, Watanabe K, Hara K, Miyazaki S. The evolution of some EEG features in normal and abnormal infants Brain Dev 1980; 2: 373-7.
Panico LR, Ríos VG, Demartini MG, Carniello MA. The electroencephalographic evolution of a group of patients on a ketonic diet. Rev Neurol 2000; 30: 8-15.
Rigatti M, Trevísol-Biterrencourt PC. Causes of late-onset epilepsy in an epilepsy clinic of Santa Catarina-Southem Brasil. Arq Neuropsiquiatr 1999; 57: 787-92.
Palacio LG, Jiménez L, Garcia HH, Jiménez ME, Sánchez JL, Noh J, et al. Neurocysticercosis in persons with epilepsy in Medellín, Colombia. The Neuroepidemiology Resach group of Antioquia. Epilepsia 1998; 39: 1334-9.
Del Bittencourt PRIVI, Adamoickum B, Barucha N, Carpio A, Hemandez-Cossio O, Danesi MA, et al. Epilepsy in the tropics. Epidemiology socioeconomic risk factor and etiology. Epilepsia 1996; 37: 1121-7.
Del Bruto OH, Noboa CA. Late-onset epilepsy in Ecuador etiology and clinical feature in 225 patients. J Trop Geor Neurol 1991; 1: 13-34.